How Much Gets there and What Does it Do?: The Need for Better Pharmacokinetic and Pharmacodynamic Endpoints in Contemporary Drug Discovery and Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|11|891-902

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.11, 2003-04, pp. : 891-902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

By Yang Bing-Bing   Lum Peggy   Chen Alin   Arends Rosalin   Roskos Lorin   Smith Brian   Ruixo Juan José Pérez  

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 729-740

Adis International

Access to resources Recommend Favorite

Applications of Computer-Aided Pharmacokinetic and Pharmacodynamic Methods from Drug Discovery Through Registration

By  

Current Computer - Aided Drug Design, Vol. 4, Iss. 1, 2008-01 ,pp. : 54-66

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Biosimilars—Pharmacokinetic and Pharmacodynamic Considerations

By Wang Yow-Ming   Chow Andrew  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 46-61

Taylor & Francis Ltd

Access to resources Recommend Favorite

Do We Need to Optimize Plasma Protein and Tissue Binding in Drug Discovery?

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 4, 2011-02 ,pp. : 450-466

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic Stability for Drug Discovery and Development: Pharmacokinetic and Biochemical Challenges

By Masimirembwa C.M.   Bredberg U.   Andersson T.B.  

Clinical Pharmacokinetics, Vol. 42, Iss. 6, 2003-01 ,pp. : 515-528

Adis International

Access to resources Recommend Favorite